AEON Biopharma, Inc.
AEON Biopharma, Inc.
AEON Biopharma, Inc. (AEON) — SEC Financial Statements & Analysis
AEON Biopharma, Inc. (AEON) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Common Class B | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Cash And Cash Equivalents At Carrying Value | 6 | 3 | 6 | 8 | 10 | 0 | 1 | 3 | 2 | 5 | 16 | 0 | |||||
Prepaid Expense Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | - | |||||
Assets Current | 7 | 3 | 7 | 10 | 12 | 2 | 2 | 4 | 2 | 6 | 17 | 1 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | - | |||||
Other Assets Noncurrent | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Assets | 9 | 6 | 9 | 12 | 14 | 3 | 4 | 6 | 3 | 7 | 18 | 22 | |||||
Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | - | - | 7 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Assets Held In Trust Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 21 | |||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 1 | 1 | 3 | 4 | 2 | 6 | 5 | 3 | 7 | 3 | 4 | - | |||||
Employee Related Liabilities Current | 2 | 3 | 2 | 1 | 0 | 1 | 2 | 1 | 1 | 1 | 1 | - | |||||
Sales And Excise Tax Payable Current | - | - | - | - | - | - | - | - | - | - | 1 | 0 | |||||
Accrued Income Taxes Current | - | - | - | - | - | - | - | - | - | - | - | 1 | |||||
Other Accrued Liabilities Current | 2 | 2 | 3 | 3 | 3 | 4 | 3 | 4 | 4 | 4 | 3 | - | |||||
Liabilities Current | 7 | 7 | 8 | 9 | 9 | 14 | 11 | 10 | 16 | 13 | 14 | 9 | |||||
Convertible Long Term Notes Payable | 2 | 35 | 17 | 15 | 13 | 12 | 15 | 13 | 5 | - | - | - | |||||
Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | 0 | - | |||||
Derivative Liabilities Noncurrent | - | 15 | - | - | - | - | - | - | - | - | - | - | |||||
Warrants And Rights Outstanding | 16 | 3 | 2 | 2 | 2 | 1 | 2 | 1 | 12 | 1 | 2 | 1 | |||||
Notes Payable Related Parties Classified Current | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Notes Payable Related Parties Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Liabilities | 25 | 61 | 29 | 28 | 25 | 32 | 36 | 34 | 201 | 160 | 146 | 12 | |||||
Temporary Equity Carrying Amount Attributable To P… | - | - | - | - | - | - | - | - | - | - | - | 21 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Additional Paid In Capital | 466 | 416 | 414 | 413 | 411 | 403 | 402 | 400 | 393 | 381 | 380 | 0 | |||||
Retained Earnings Accumulated Deficit | -483 | -471 | -434 | -429 | -423 | -432 | -434 | -428 | -592 | -474 | -447 | -11 | |||||
Stockholders Equity | -17 | -55 | -20 | -16 | -11 | -29 | -32 | -28 | -198 | -153 | -128 | -11 | |||||
Liabilities And Stockholders Equity | 9 | 6 | 9 | 12 | 14 | 3 | 4 | 6 | 3 | 7 | 18 | 22 | |||||
Common Class A | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Common Classa Subject To Redemption | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Common Classa Not Subject To Redemption | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Preferred Stock Shares Authorized | - | - | - | - | - | - | - | - | - | - | - | 1 | |||||
Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Notes Payable Current | - | - | - | - | - | - | - | - | - | 0 | 0 | - | |||||
Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Related Party | 2 | 35 | 2 | 2 | 13 | 12 | 2 | 13 | - | 0 | - | - | |||||
Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | 0 | 0 | - | |||||
Treasury Stock Shares | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Common Stock Shares Authorized | 1,040 | 1,040 | 1,040 | 1,040 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | - | |||||
Common Stock Shares Issued | 25 | 24 | 23 | 23 | 21 | 1 | 40 | 39 | 38 | 37 | 37 | - | |||||
Shares Outstanding | 51 | 48 | 47 | 46 | 42 | 47 | 1,108 | 1,095 | 1,067 | 1,040 | 1,040 | - | |||||
Treasury Stock Common Shares | - | - | - | - | - | - | - | - | - | 0 | 0 | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -9.86% | -10.74% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 64.66% | 68.27% | 36.55% | 10.74% | 17.56% | 23.37% | -25.75% | 22.65% | 28.18% | 6.06% | -21.52% | -32.53% |
| 2024 | 3.07% | -40.00% | -35.58% | -23.10% | 21.00% | -12.00% | -6.38% | -17.54% | -81.30% | -44.06% | -30.94% | 25.83% |
| 2023 | -2.22% | -27.05% | -23.00% | -35.24% | -56.00% | -38.56% | 46.25% | 70.46% | 74.33% | - | - | - |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.99 | 0.49 | 0.90 | 1.12 | 1.43 | 0.11 | 0.22 | 0.39 | 0.16 | 0.48 | 1.19 | 0.06 | |||||
| Quick Ratio | 0.94 | 0.44 | 0.72 | 0.92 | 1.21 | 0.00 | 0.05 | 0.33 | 0.10 | 0.40 | 1.14 | 0.05 | |||||
| Working Capital | -44.00K | -3.50M | -816.00K | 1.13M | 3.68M | -12.56M | -8.36M | -6.41M | -13.46M | -6.83M | 2.73M | -8.87M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.52 | -1.10 | -1.44 | -1.74 | -2.22 | -1.11 | -1.12 | -1.21 | -1.02 | -1.04 | -1.14 | -1.05 | |||||
| Debt Ratio | 2.94 | 10.90 | 3.28 | 2.36 | 1.82 | 10.09 | 9.01 | 5.87 | 66.43 | 23.36 | 8.29 | 0.55 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -1.48 | -0.99 | -0.00 | -0.04 | 3.54 | 0.87 | 0.39 | 1.64 | -2.15 | 0.55 | 1.06 | -0.06 | |||||
| Free Cash Flow Per Share TTM | -0.30 | -0.44 | -0.28 | -0.31 | -0.41 | -0.45 | -0.21 | -0.48 | -0.54 | -0.60 | -0.23 | -0.55 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | -135.54% | -193.37% | -100.02% | -102.20% | -280.71% | 74.69% | -60.89% | -2,968.67% | -3,012.26% | 277.17% | 605.13% | -124.61% | |||||
| EPS Growth (1Y) | -141.85% | -206.79% | -100.02% | -102.25% | -264.41% | 66.85% | -63.24% | -2,661.49% | -2,810.49% | 250.18% | 558.68% | -124.47% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.67 | -1.11 | -12,550.23 | -20.61 | 0.16 | 42.01 | 193.63 | 46.03 | -388.27 | 934.63 | 379.58 | -7,950.89 | |||||
| P/B | -2.39 | -0.79 | -1.89 | -2.13 | -2.45 | -61.77 | -108.68 | -122.67 | -183.16 | -146.85 | -136.14 | -1,800.91 | |||||
| Market Cap | 40.00M | 43.65M | 37.65M | 33.72M | 27.73M | 1.76B | 3.49B | 3.43B | 36.34B | 22.47B | 17.48B | 20.64B | |||||
| Enterprise Value | 35.30M | 75.25M | 48.77M | 40.45M | 30.61M | 1.78B | 3.50B | 3.44B | 36.34B | 22.47B | 17.46B | 20.64B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -12.04M | -17.32M | -13.23M | -13.58M | -19.61M | -20.29M | -9.55M | -21.65M | -23.62M | -26.08M | -9.95M | -22.16M | |||||
| Net Debt | -4.70M | 31.59M | 11.12M | 6.74M | 2.87M | 11.68M | 14.63M | 9.85M | 3.53M | -5.16M | -16.18M | -2.60M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data